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Abstract—Patient-speciﬁc modelling has emerged as a tool
for studying heart function, demonstrating the potential to
provide non-invasive estimates of tissue passive stiffness.
However, reliable use of model-derived stiffness requires
sufﬁcient model accuracy and unique estimation of model
parameters. In this paper we present personalised models of
cardiac mechanics, focusing on improving model accuracy,
while ensuring unique parametrisation. The inﬂuence of
principal model uncertainties on accuracy and parameter
identiﬁability was systematically assessed in a group of
patients with dilated cardiomyopathy (n ¼ 3) and healthy
volunteers (n ¼ 5). For all cases, we examined three circum-
ferentially symmetric ﬁbre distributions and two epicardial
boundary conditions. Our results demonstrated the ability of
data-derived boundary conditions to improve model accu-
racy and highlighted the inﬂuence of the assumed ﬁbre
distribution on both model ﬁdelity and stiffness estimates.
The model personalisation pipeline—based strictly on non-
invasive data—produced unique parameter estimates and
satisfactory model errors for all cases, supporting the selected
model assumptions. The thorough analysis performed
enabled the comparison of passive parameters between
volunteers and dilated cardiomyopathy patients, illustrating
elevated stiffness in diseased hearts.
Keywords—Stiffness, Myocardium, Patient-speciﬁc mod-
elling, Model uncertainties, Parameter uniqueness.
INTRODUCTION
With cardiovascular disease being the leading cause
of death worldwide,37 signiﬁcant research effort has
been devoted to understanding heart function in health
and pathology. As a wide range of aetiologies have
been attributed to cardiac conditions, determining the
factors inﬂuencing disease in individual patients—and
selecting appropriate treatments—remains an ongoing
challenge. In some cases, such as hypertrophic car-
diomyopathy, myocardial infarction and diastolic
heart failure, abnormalities in tissue stiffness have been
identiﬁed as features of the disease.36 Structural alter-
ations associated with the severity of the condition
appear to be reﬂected in myocardial stiffness,5,7 sug-
gesting its potential clinical utility in improving patient
assessment and providing tailored treatment strategies.
Quantiﬁcation of myocardial stiﬀness is not a
straightforward task. Shear and stretch tests have been
performed on animal and human tissue samples9,32 to
provide a basis for estimation of myocardial proper-
ties.16,30 While the utility of these studies can hardly be
overstated, the numerical values obtained from ex vivo
data cannot necessarily be directly applicable in per-
sonalised in vivo studies. Alternatively, a number of
techniques have been proposed that merge clinical data
with mathematical models of varying complexity to
obtain an indirect approximation to patient-speciﬁc
myocardial properties. These range from established
chamber stiffness estimates derived from pressure-
volume curves5 or wall stress surrogates1 to developing
Address correspondence to Myrianthi Hadjicharalambous,
Division of Imaging Sciences and Biomedical Engineering, King’s
College London, St. Thomas’ Hospital, London SE1 7EH, UK.
Electronic mail: myrianthi.hadjicharalambous@kcl.ac.uk
Annals of Biomedical Engineering, Vol. 45, No. 3, March 2017 ( 2016) pp. 605–618
DOI: 10.1007/s10439-016-1721-4
0090-6964/17/0300-0605/0  2016 The Author(s). This article is published with open access at Springerlink.com
605
detailed 2D or 3D strain estimates derived from
Doppler echocardiography10,19 or magnetic resonance
(MR) images4,34 to emerging wave propagation
velocity estimates in shear wave ultrasound8,15 and
MR elastography.24,29
Incorporating personalised geometries and loading
conditions along with more physiologically accurate
material responses, patient-speciﬁc modelling presents
an alternative for stiﬀness estimation. In particular,
data-derived information such as cavity volumes7 and
pressures3,13 has been used to quantify model passive
stiffness. The transition from bulk measures to more
comprehensive data, such as tissue displacements and
strains, has enabled more elaborate approaches for
estimating a larger number of parameters12,35 and
heterogeneous parameter distributions.25,38 As recent
advances in medical imaging offer increasingly more
detail on the heart anatomy and regional kinematics,
rich datasets for model personalisation and charac-
terisation of passive parameters are becoming more
accessible.2,14,39
Despite the wealth of clinical data available and the
continuous enhancements in the complexity and
accuracy of personalised models, signiﬁcant work is
still required to enable the translation of model-based
stiﬀness assessment to the clinic. A fundamental pre-
requisite is the reliable quantiﬁcation of myocardial
stiﬀness, an issue tightly coupled to the unique and
accurate estimation of model parameters which was
analysed in our previous study.14 Brieﬂy, while
extracting an error-minimising set of parameters is
generally attainable, demonstrating that the obtained
estimates are meaningful—and thus potentially clini-
cally useful—requires ensuring parameter uniqueness.
While previous studies have proposed a variety of
techniques for obtaining unique parameter esti-
mates,13,38 reliable parametrisation also depends on
the model’s ability to accurately represent individual
hearts (model ﬁdelity), raising the core challenge of
dealing with model uncertainties.14 Important mod-
elling aspects such as the unstressed reference domain,
the material law or appropriate boundary conditions
remain relatively unknown, despite the wide range of
experimental and modelling studies. Additionally,
measurements such as Diffusion Tensor MRI
(DTMRI) or cavity pressures which are valuable in
model personalisation are often not part of routinely
acquired clinical data, introducing further model
uncertainties. Previous works have employed a variety
of constitutive laws,12,35 rule-based ﬁbre distributions39
and data-derived reference geometries2,7 to address
these uncertainties; however, the suitability of the
embedded model assumptions has not yet been sys-
tematically assessed in real data. Examining the inﬂu-
ence of such assumptions on error—and hence model
accuracy—illustrates potential improvements within a
given model.
With these concerns in mind, in this work we de-
velop patient-speciﬁc models of cardiac mechanics,
focusing on the need for reliable parametrisation. The
personalised models are built using comprehensive
state-of-the-art clinical data [cine and 3D tagged MRI
(TMRI)] which were non-invasively acquired. A re-
duced version of the Holzapfel–Ogden16 law is em-
ployed, in accordance with our previous works2,14
whereby it was identiﬁed as a suitable choice for
parameter estimation applications based on TMRI.
Important model uncertainties are systematically
examined, with the objective of improving model
accuracy while ensuring stiffness identiﬁability. In
particular, we examine the inﬂuence of the ﬁbre dis-
tribution on model ﬁdelity, as ﬁbre architecture is a key
determinant of cardiac function. Epicardial boundary
conditions are also investigated, as a means of incor-
porating data into the model and enhancing model ﬁ-
delity. The robustness and suitability of the selected
assumptions are assessed in healthy volunteers (n ¼ 5)
and patients with dilated cardiomyopathy (DCM,
n ¼ 3). Due to the ventricular remodelling observed in
DCM hearts, passive parameters are expected to differ
between the two groups,7,18,27,28 providing a frame-
work for evaluating the proposed approach for stiff-
ness assessment. Finally, having veriﬁed unique
parametrisation, we compare parameters between
volunteers and patients, enabling a preliminary
assessment of variation in stiffness between healthy
and DCM hearts.
Below, we expand on our approach to estimate and
study myocardial stiﬀness through patient-speciﬁc
modelling. Building on the data processing and model
development protocol presented in our recent stud-
ies2,14 in ‘‘Materials and Methods’’ section, we review
the process followed for the creation of personalised
models. Modelling aspects that can inﬂuence model
ﬁdelity and parameter identiﬁability in vivo are exam-
ined in ‘‘Results’’ section, allowing comparisons
between DCM patients and healthy volunteers. Our
ﬁndings are reviewed and discussed in ‘‘Discussion’’
section, providing directions for future research.
MATERIALS AND METHODS
In this section we present the process followed for
assessing stiﬀness using personalised diastolic left ven-
tricular (LV) models of cardiac mechanics. The model
personalisation pipeline, summarised in Fig. 11, is pre-
1Images were created using Eidolon (https://github.com/ericspod/
Eidolon), developed by Dr Eric Kerfoot at King’s College London.
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sented in ‘‘Data Processing Pipeline’’ section. The
mechanics model is then reviewed along with the
process for estimating model parameters (‘‘Person-
alised Cardiac Mechanics Model’’ section). To assess
the reliability of the obtained parameters we examine
model uncertainties that can inﬂuence and improve
parameter identiﬁability and model accuracy (‘‘Model
Fidelity and Parameter Identiﬁability Study’’ section).
Data Processing Pipeline
Clinical data was collected from 5 volunteers with
healthy heart function (V1–V5) and 3 DCM patients
(P1–P3), recruited at St Thomas’ hospital. The study
included male and female participants, with ages
ranging from 28 to 55 (Table 1). Cardiac MRI scans
(Table 2) were performed on a 1.5T Philips Achieva
system. Written informed consent was obtained from
all participants prior to scanning, and the protocol
(study number 12/LO/1456) was approved by the
London Bridge NRES committee.
In order to enable consistent use of the available
data, spatial registration of images was performed
using the Image Registration Toolkit (IRTK)2. Image
registration was essential to minimise misalignment
between images caused by changes in patient’s position
and breathing pattern. It is worth noting that incon-
sistencies between breath holds were decreased by
using an MRI respiratory navigator during the acqui-
sition of the SA stack.
LV meshes were created based on manual segmen-
tations of end-diastolic cine images. Myocardial wall
and cavity segmentations of SA, 2CH, 3CH and 4CH
images were created using ITK-SNAP,41 and merged
into one isotropic mask, which was further reﬁned and
smoothed. A template surface mesh based on a statisti-
cal atlas17 was then ﬁtted to the mask and truncated at
the base of the heart. Subsequently, the warped surface
mesh was used to create a volumetric linear tetrahedral
mesh using Cubit3 and TetMesh-GHS3D by Distene
S.A.S./INRIA. Basic characteristics of LV meshes are
presented in Table 3. All personalised meshes have a
mesh size h of approximately 3–4 mm. The speciﬁcmesh
size is sufﬁciently small to allow for accurate parameter
estimation,3 yet sufﬁciently large to enable the small
computational cost required for the large number of
parameter sweeps performed.
Myocardial wall motion was extracted from TMRI
images using a non-rigid registration algorithm in
IRTK.31 The registration algorithm which is based on
optimisation of a similarity measure between images
and free-form deformations was applied only on
TMRI images. A myocardial mask was used during
motion tracking to restrict the effect of surrounding
FIGURE 1. Workflow followed for the development and analysis of personalised diastolic heart models. Following spatial reg-
istration of images, segmentations of end-diastolic cine images were used to create an LV mesh, on which motion extracted from
TMRI was propagated through the cardiac cycle. Personalised models were driven by extracted cavity volumes, while data-derived
boundary conditions were applied on the basal and epicardial boundaries. Finally, parameter estimates were obtained through
minimisation.
2http://www.doc.ic.ac.uk/dr/software. 3https://cubit.sandia.gov/.
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tissues and organs. The extracted motion was applied
onto the end-diastolic mesh, resulting in deformed
meshes following the heart motion throughout the
cardiac cycle. Extracted displacements were then pro-
cessed to ensure conservation of myocardial volume
(section S1 in supplement). Extracted and processed
motion were compared against manually tracked
landmark points (section S2), presenting satisfactory
accuracy in both cases.
End-diastolic pressures were estimated based on a
common clinical surrogate, the E=Ea ratio, proposed
by Nagueh et al.,26 where E denotes the peak early
diastolic ﬂow velocity through the mitral valve and Ea
denotes the early diastolic velocity of the mitral valve
annulus (E ¼ 1:24E=Ea þ 1:9). E was measured
from 4D PCMRI using GyroTools GTFlow4 and Ea
TABLE 1. Participants’ general information and global LV indices.
Case Age (years) G EDV (ml) ESV (ml) SV (ml) EF WTED (mm) WTES (mm)
LA
SA EDP
est (mmHg)
Volunteers
V1 28 M 129.5 64.6 64.9 0.50 8.03 10.61 1.35 10.5
V2 29 F 100.9 47.7 53.2 0.53 7.09 9.07 1.59 16.1
V3 48 M 152.6 67.4 85.1 0.56 8.73 12.1 1.40 10.2
V4 35 F 93.2 46.0 47.2 0.51 6.58 8.74 1.59 8.8
V5 41 M 120.4 53.5 66.9 0.56 8.38 11.38 1.33 11.4
Mean 36.2 – 119.3 55.8 63.5 0.53 7.76 10.34 1.45 11.4
SD 8.4 – 23.6 9.7 14.6 0.03 0.90 1.45 0.13 2.8
DCM patients
P1 28 F 141.1 81.9 59.2 0.42 7.92 10.11 1.23 16.3
P2 55 M 179.3 95.2 84.1 0.47 7.94 10.33 1.21 17.6
P3 43 F 136.2 79.9 56.3 0.41 6.54 8.24 1.24 11.6
Mean 42 – 152.2 85.7 66.5 0.43 7.46 9.56 1.22 15.2
SD 13.5 – 23.6 8.3 15.3 0.03 0.80 1.15 0.18 3.2
G gender, EDV end-diastolic volume, ESV end-systolic volume, SV stroke volume, EF ejection fraction, WTED and WTES wall thickness at
end diastole and end systole, LA/SA ratio of long-axis to short-axis dimensions at end diastole, EDPest estimated end-diastolic pressure.
Metrics are based on TMRI processed motion and their computation is summarised in section S2 in Supplementary Material.
TABLE 2. Basic information on the images acquired for all participants, in either prospective, P, or retrospective, R, ECG gating
(ECG G).
Image type ECG G SR (mm) TR (ms)
SA R 2 9 2 9 8 20–30
2CH R 2 9 2 20–30
3CH R 2 9 2 20–30
4CH R 2 9 2 20–30
TMRI P 3 9 3 9 7 rec. 1 9 1 9 1 29–32
4D PCMRI P 2.5 9 2.5 9 2.5 35–40
Images included cine MRI (in short-axis (SA) and long-axis 2-chamber (2CH), 3-chamber (3CH) and 4-chamber (4CH) views), TMRI and 4D
Phase Contrast MRI (4D PCMRI). SR and TR denote spatial and temporal resolutions respectively. Both acquired and reconstructed (rec.)
spatial resolutions of TMRI are presented.
TABLE 3. Here, LNodes and QNodes refer to the number of linear and quadratic nodes, respectively and h refers to the mesh size
in mm.
Personalised LV meshes
Case V1 V2 V3 V4 V5 P1 P2 P3
Elements 17,153 18,896 8,038 6,787 7,795 10,740 17,047 10,731
LNodes 4,048 4,375 2,327 2,050 2,088 2,747 4,173 2,986
QNodes 27,589 30,068 14,580 12,657 13,499 18,104 28,012 19,025
h ± STD (h) 3.33 ± 0.53 2.98 ± 0.27 4.43 ± 1.09 3.88 ± 0.82 4.34 ± 0.34 3.90 ± 0.56 3.47 ± 0.53 3.45 ± 0.67
q ± STD (q) 0.81 ± 0.10 0.83 ± 0.09 0.73 ± 0.14 0.74 ± 0.12 0.86 ± 0.09 0.75 ± 0.12 0.82 ± 0.10 0.78 ± 0.13
Element quality q was computed as q = 3r, r being the ratio of inradius to circumradius. The mesh size was computed as h ¼ detðSÞ1=3, S
being the affine mapping between elements in mesh and the unit right tetrahedron.
4http://www.gyrotools.com/products/gt-ﬂow.html.
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velocity was estimated at the lateral basal region using
the displacements extracted from TMRI.
The presented data processing steps were essential
for model personalisation, but also enabled the
derivation of important clinical metrics (Table 1),
allowing for additional comparisons between patients
and volunteers.
Personalised Cardiac Mechanics Model
The mechanics of the personalised diastolic models
were solved using the principle of stationary potential
energy, following Asner et al.2,3. Brieﬂy, the myo-
cardium is initially deﬁned by the reference domain
X0  R3 and initial coordinates X 2 X0. At time t, as
the heart model deforms it is described by its physical
domain XðtÞ  R3, using the coordinates of its current
position x ¼ Xþ u (u denotes the displacement). For
the models considered, the myocardium was assumed
to be incompressible. The potential energy P of the
myocardium can then be written as a sum of the
myocardial internal and external energies2,3
Pðu; p; kÞ ¼ Pintðu; pÞ þPextðu; kÞ; ð1Þ
where u, p and k denote displacement, hydrostatic
pressure and boundary Lagrange multipliers respec-
tively (see ‘‘Constitutive Law’’ and ‘‘Boundary Con-
ditions’’ sections). The primary variables (u; p; k) are
found as the saddle-point solution of the potential
energy functional:
Pðu; p; kÞ ¼ inf
v2U
sup
ðqlÞ2WK
Pðv; q; lÞ; ð2Þ
minimising the internal energy of the system, while
ensuring enforcement of the incompressibility and
boundary constraints. Here UW K are appropri-
ate function spaces.2,3
As no undeformed, unstressed state is encountered
during the cardiac cycle, the reference geometry needs
to be either estimated using an inverse method23 or
assumed to be approximated by data. Due to chal-
lenges in estimating the reference domain, arising from
its dependence on constitutive law, material parame-
ters and boundary conditions,2 selecting a data frame
as the reference domain is a common approach.12,35,38
For the personalised models considered, the end-sys-
tolic frame of the extracted TMRI motion was
assumed as the reference geometry X0.
Furthermore, due to the absence of data on the ﬁbre
architecture of each participant’s heart, a rule-based
ﬁbre distribution was applied for all cases. A circum-
ferentially symmetric ﬁbre ﬁeld was used, with the ﬁbre
angle varying linearly between þh and h from
endocardium to epicardium.33 Although h ¼ 60 is
commonly used, three different ﬁbre distributions were
considered (i.e. h ¼ f50; 60; 70g).
Constitutive Law
The internal energy Pint of the myocardium is
dependent on the material properties of the tissue and
the model selected to describe them. The myocardial
tissue was assumed to be a hyperelastic, incompressible
material, for which the internal energy Pint can be
expressed with respect to a strain energy function W, as
Pintðu; pÞ ¼
Z
X0
WðuÞ þ pðJ 1ÞdV: ð3Þ
In this case J denotes the determinant of the defor-
mation gradient F ¼ rXuþ I.
The choice of constitutive law was dictated by one
of the basic objectives of this work, namely suﬃcient
model ﬁdelity and unique parametrisation. In previous
works with synthetic and real TMRI,2,14 a reduced
version of the structurally-based Holzapfel–Ogden16
model was shown to satisfy these requirements.
Accordingly, the passive response of the myocardium
was modelled as:
WðuÞ ¼ a
2b
exp½bðIIF  3Þ  1ð Þ
þ af
2bf
exp½bfðIIFf  1Þ2  1
 
;
ð4Þ
with isotropic a, b and ﬁbre af, bf material parameters.
Here IIF ¼ F : F denotes the second invariant of F.
This constitutive law accounts for the different mate-
rial properties along the ﬁbre direction f0, by using an
invariant associated with ﬁbres (IIFf ¼ Ff0 : Ff0). To
restrict the number of parameters and assist unique
parametrisation, the exponents b and bf were not
estimated but instead kept constant. The values used
(b ¼ 5, bf ¼ 5) were chosen to ensure a physiological
(and pathological for DCM patients) pressure-volume
response,14 based on the empirical curve of Klotz
et al.20 Although the estimates of a and af are depen-
dent14 on the speciﬁc choice of b and bf, assigning the
same values to the exponents across cases allows for
reliable comparisons of a and af between cases.
Boundary Conditions
The external energy Pext of the LV models was
comprised of the sum of external boundary-based en-
ergies, applied on the basal (b), endocardial (‘) and
epicardial (e) surfaces. Data-derived constraints were
enforced using Lagrange multipliers kk, resulting in the
following form for the external energy,
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Pextðu; kÞ ¼
X
k2ðb;‘;eÞ
Pkextðu; kkÞ: ð5Þ
Overcoming the need for invasive cavity pressure
measurements—commonly prescribed on the endo-
cardial boundary7,35—in this work diastolic simula-
tions were driven using cavity volume which can be
easily extracted from routinely acquired images. Vol-
ume inﬂation was achieved by ensuring that the mesh
lumen volume was equal to the data-derived cavity
volume at every time step, using the Lagrange multi-
plier approach, as described in Asner et al.2,3
A data-derived constraint was also applied on the
base plane, which was set to follow the TMRI ex-
tracted motion. Following Asner et al.,2,3 a relaxed
basal boundary condition was employed to restrict the
inﬂuence of noisy tracked data on the model and avoid
pressure and stress peaks arising with strict enforce-
ment of displacement constraints.
A common practice in cardiac patient-speciﬁc
applications is to assume that the epicardial energy is
negligible. This approach was also examined in this
work and will be referred to as the ‘‘No-traction
boundary condition’’ (NT BC). The right ventricle
(RV) is likely, however, to exert a substantial force on
the septal wall of the LV during ﬁlling. To account for
this eﬀect, a relaxed boundary condition on the epi-
cardial boundary was also examined, which incorpo-
rated data-derived motion on the region of attachment
to the RV wall (RV BC). The speciﬁc region was de-
ﬁned through a spatial ﬁeld H varying smoothly
between 0 and 1, marking the RV attachment points
with 1. In this case, the following form was used for the
epicardial boundary energy,
Peextðu; keÞ ¼
Z
Ce0
ke  ðu udÞH 1
2
eke
 
dA; ð6Þ
where Ce0 is the undeformed epicardial surface, ud is the
data displacement and ke is the introduced Lagrange
multiplier on the epicardial boundary. Three different
values were considered for the relaxation parameter
(e ¼ f5 108; 5 106; 5 104g) and the moderate
value (e ¼ 5 106) was found to provide satisfactory
adherence to the data without introducing spurious
stresses.
Numerical Solution
The personalised models were solved using the ﬁnite
element method. Speciﬁcally, a quadratic-linear inter-
polation scheme was employed for the displacement
and hydrostatic pressure variables, respectively. The
base and epicardial multipliers were approximated
with quadratic triangular elements while the endocar-
dial multiplier was a scalar. All problems were solved
using CHeart, a multi-physics ﬁnite element solver.22
Parameter Estimation
Estimation of material parameters (a, af) in Eq. (4)
was achieved by minimising the objective function J ,
based on the L2ðX0Þ norm of the relative error through
time:
J ¼
PN
n¼1
jjun  undjj2
PN
n¼1
jjundjj2
0
BBB@
1
CCCA
1=2
: ð7Þ
Here und and u
n are the data-derived and model-pre-
dicted displacements at timestep n, respectively, and N
is the number of diastolic frames identiﬁed in the
available TMRI data.
In volume-driven simulations, estimation of both a
and af parameters is not feasible using solely dis-
placement observations. Due to the linear parameter
dependence of the reduced Holzapfel–Ogden law,
scaling of both passive parameters only scales cavity
pressure but does not affect the displacements out-
come. Nevertheless, exploiting this property we can
restrict the parameter space to only one unknown, the
parameter ratio c ¼ a=af. c was estimated through
parameter sweeps, which—even though computation-
ally costly—provide a characterisation of parameter
identiﬁability. The parameter sweeps (23 values were
considered for c, ranging between 0.3 and 2) were
performed by keeping the ﬁbre parameter asimf constant
and varying asim. An arbitrary value ( asimf ¼ 1000Pa)
was used for the ﬁbre parameter over sweeps. As any
scaling of asimf will proportionally scale k
ED
‘ , the abso-
lute values of both parameters (a, af) can then be
computed by scaling by the ratio between estimated
(EDPest) and simulated (kED‘ ) end-diastolic pressure as:
a ¼ asim EDP
est
kED‘
¼ 1000cEDP
est
kED‘
;
af ¼ 1000EDP
est
kED‘
:
ð8Þ
To enable more accurate parameter estimates using
RV BC and h ¼ 50, parameter sweeps were aug-
mented with values closer to the previously obtained c
estimates.
Model Fidelity and Parameter Identiﬁability Study
Despite the variety of clinical data available which
enabled the model personalisation presented in ‘‘Data
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Processing Pipeline’’ and ‘‘Personalised Cardiac
Mechanics Model’’ sections, certain modelling aspects
could not be determined and needed to be based on
literature studies. With the objective of achieving reli-
able parametrisation through improving model accu-
racy, model assumptions regarding ﬁbre distribution,
suitable boundary conditions and the reference state
were carefully analysed. The pipeline was applied with
perturbations of these assumptions on all volunteer
and patient cases, to enable a systematic assessment of
model uncertainties. Model accuracy and parameter
identiﬁability were then examined through characteri-
sation of the objective function J in Eq. (7) over the
parameter space (c). The values of J , the relative dis-
placement error, at the estimated parameter were used
to assess model accuracy, while the overall behaviour
of J provided a characterisation of parameter identi-
ﬁability.
Three diﬀerent ﬁbre distributions were examined, as
discussed in ‘‘Personalised Cardiac Mechanics Model’’
section, with the maximum angle h ¼ f50; 60; 70g.
The effect of the epicardial boundary condition on
model ﬁdelity and parameter identiﬁability was also
assessed, by considering both NT BC and RV BC, as
discussed in ‘‘Boundary Conditions’’ section. Addi-
tionally, different data frames were employed as ref-
erence state, and compared with respect to their
inﬂuence on both accuracy and identiﬁability.
RESULTS
Model Fidelity and Parameter Identiﬁability In Vivo
Focusing on the need for reliable model parameters,
this section examines model accuracy and parameter
identiﬁability for all cases. Figure 2 illustrates the be-
haviour of J over the parameter ratio c, for V5 (results
for V1–V4 and P1–P3 are presented in supplementary
material), with the three model ﬁbre distributions and
the NT BC / RV BC. Each data-point within these
graphs represents a speciﬁc diastolic simulation com-
pared to the tracked data. Additionally, Table S2
summarises c estimates for all cases.
The eﬀect of the employed epicardial boundary
condition on all models is summarised in Fig. 3, which
presents the change in model error. Similarly, Fig. 4
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FIGURE 2. J over the parameter ratio c for V5, for h ¼ f50; 60; 70g and NT BC / RV BC. Also presented are data-derived (mesh
lines) and simulated (surface) end-diastolic states, with colour showing the error magnitude in metres.
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illustrates the inﬂuence of the ﬁbre angle h on model
error and parameter estimates, in both volunteers and
patients. Normalised values were used for both the
objective function and parameter ratio estimates, to
allow for comparison of the ﬁbre angle effect between
cases with different error/parameter ratio magnitudes.
To assess the inﬂuence of the reference state, dif-
ferent diastolic frames were considered as reference X0
and the change in the behaviour of the objective
function was investigated. Figure 5 compares J when
different diastolic frames (end-systolic, second and
fourth after end-systolic) were used, for a volunteer
and a patient case (results for remaining cases are
presented in the Supplementary Material).
Comparative Analysis of In Vivo Cases
Following the results in ‘‘Model Fidelity and
Parameter Identiﬁability In Vivo’’ section, a compar-
ative analysis between volunteers and DCM patients
was performed. Differences in clinical metrics (Table 1)
between DCM and normals were analysed and un-
paired t-tests were performed to assess their statistical
signiﬁcance. Variations in important metrics between
the two groups are illustrated in Fig. 6. We note that
reported cavity volumes differ from standard clinical
volume measures due to the truncation of the LV mesh
at a plane lower than the valve plane. As the truncation
of the LV meshes cannot be easily standardised, vol-
umes in Fig. 6 were normalised by the end-diastolic
long-axis length to avoid biased comparisons.
Based on the analysis in ‘‘Model Fidelity and
Parameter Identiﬁability In Vivo’’ section, model re-
sults were tabulated for RV BC and h ¼ 50 for all
cases. Parameter estimates are presented in Fig. 7,
along with a schematic comparison of passive param-
eters between volunteers and patients.
DISCUSSION
Model Fidelity and Parameter Identiﬁability
The ability of the model to accurately represent the
mechanical behaviour of individual hearts is a pre-
requisite for the reliable estimation of stiﬀness with
patient-speciﬁc modelling. Based on the tests pre-
sented, the boundary conditions and the employed ﬁ-
bre distribution were key factors in model accuracy.
In particular, observing the values of the objective
function in Figs. 2 and 3, the application of the da-
ta-derived motion on the region of attachment to the
RV proved superior compared to the simpliﬁed zero-
traction epicardial boundary condition. In fact, the
average model error decreased from approximately
 45 to  25% and from  51 to  26%, in the vol-
unteer and patient groups respectively. The signiﬁcant
error reduction is also qualitatively illustrated in me-
shes in Fig. 2.
The application of RV BC also resulted in better
identiﬁability characteristics as can be observed in
FIGURE 3. Model error (minimum value of the objective function) Jmin across fibre angle h, using NT BC and RV BC, for all the
volunteers (in black) and DCM patients (in grey).
FIGURE 4. Effect of fibre distribution on (left) model error and
(right) parameter ratio estimates, when the RV BC is employed.
Here, normalised magnitudes are used for the objective func-
tion and parameter ratio estimates (f^ ¼ f ðhÞmin f ðhÞmax f ðhÞmin f ðhÞ) and bars
show average values over the volunteer and patient groups.
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Fig. 2. Speciﬁcally, the variation in J (difference
between maximum and minimum J values) increased
with RV BC, in accordance with the fact that sufﬁcient
model ﬁdelity is a requirement for parameter identiﬁ-
ability.14 It is worth mentioning that the identiﬁability
characteristics were also dependent on the magnitude
of deformation, with a substantial deformation
required for parameter identiﬁability. Accordingly,
parameter identiﬁability was in general better in the
healthy volunteers compared to DCM patients, where
the cardiac deformation is lower.
The employed ﬁbre architecture was also shown to
notably impact model behaviour and parameter esti-
mates. Firstly, based on Table S2 and Fig. 4, param-
eter ratio estimates were strongly coupled to the
assumed ﬁbre distribution. As the ﬁbre angle increases
we observe a greater trend toward anisotropy (e.g. c
decreases). Furthermore, in the majority of cases
employing the RV BC, the lowest error was obtained
with a ﬁbre angle of h ¼ 50. This observation holds
for all volunteer cases with a mean difference of 4:2%
in J , between h ¼ 50 and h ¼ 70. Although h ¼ 50
also produced on average lower errors in the DCM
group, the difference in error between h ¼ 50 and
h ¼ 70 was less pronounced compared to the observed
changes in the volunteer group. This observation sug-
gests that angles could be steeper for DCM with
minimal effect on the model. This would be in agree-
ment with recent DTMRI studies,11 suggesting
increased ﬁbre angle in DCM.
Restricting the study to models employing the RV
BC and a ﬁbre distribution of h ¼ 50, we can observe
good identiﬁability characteristics for all cases.
The presence of a clear minimum was combined with
FIGURE 5. Objective function J over the parameter ratio c, with three different data frames (end-systolic (ES), the second and
fourth after ES) assumed as the reference, for (left) V1 and (right) P1. Bisected meshes present ES (grey) and ES+4 (red)
geometries.
FIGURE 6. Comparison of data-derived metrics between the volunteer and patient groups. Red lines show the median, the boxes’
edges denote 25th and 75th percentiles, while black lines show extreme data points.
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reasonable errors (17–34% and 18–33%, for volunteer
and patient groups, respectively), especially consider-
ing the strict metric used for J (relative L2 error norm,
accumulated over time). A good agreement between
the model and the data was also presented in their
average nodal distance in Table S3. With data varying
notably in quality and consistency, the satisfactory
errors observed not only suggest the potential of model
assumptions but also illustrate the robustness of the
model personalisation pipeline. Complementary eval-
uation of model accuracy was provided through re-
gional strain distributions (Fig. S7 in the Supplemen-
tary Material) which demonstrated marked similarities
between data and models.
Changing the reference frame between early-mid
diastolic frames did not appear to aﬀect parameter
identiﬁability, with a unique minimum present for all
reference geometries and in all cases. However, the
parameter estimates were dependent on the frame
employed. In particular, a consistent behaviour was
observed for all volunteer cases, with the parameter
ratio increasing when later data-frames were assumed
as the reference domain. Similar behaviour was
observed in the patient group, with two patients
demonstrating increase in c and P3 presenting a small
decrease in c when later frames were employed. Al-
though the parameters were dependent on the frame
selected as reference, the consistency in behaviour
between cases in Figs. 5 and S6 suggests that the choice
of reference state may introduce a consistent bias in the
results, maintaining the ability for reliable compar-
isons between cases.
Comparative Analysis of In Vivo Models
Despite the small number of volunteers and
patients, distinct diﬀerences were identiﬁed in data-
derived metrics between the two groups (Table 1;
Fig. 6). Pronounced increases (p 	 0:05) were observed
in end-diastolic and end-systolic cavity volumes in
DCM hearts, as extensively reported in literature.1,40
Ejection fraction was considerably lower in the patient
group (p 	 0:005), marking the deteriorated contractile
and diastolic ﬁlling function typically clinically asso-
ciated with DCM. Additionally, the decrease in the
ratio of long-axis to short-axis dimensions observed in
patients is characteristic of the change in shape
from elliptical to spherical in DCM.21 Wall thick-
ness was moderately decreased in DCM patients
compared to normals both at end diastole and end
systole, in accordance to other studies.27 A more evi-
dent trend was observed in the wall thickening ratio
ðtES  tEDÞ=tES (p ¼ 0:07) and the normalised long-axis
shortening ðLAED  LAESÞ=LAED (p 	 0:005), with
both quantities decreasing in the DCM group. Similar
ﬁndings have been reported in the literature,40 indi-
cating reduced wall thickening during contraction and
thus impaired contractile function in the presence of
DCM. Analogous conclusions were also drawn from
the magnitude of deformation (Table S3) as well as
from regional strain distributions (Table S4) which
indicated decreased strain metrics in DCM hearts
compared to volunteers. Another key distinction
was observed in the estimated end-diastolic pressure
(EDPest). In accordance with previous studies,1,21
(a) (b)
FIGURE 7. (a) Parameter estimates (c, a and af ) for the volunteers and patients, along with the simulated end-diastolic pressure,
kED‘ . (b) Comparison of (top) isotropic parameter a and (bottom) fibre parameter af between the volunteer and patient groups.
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EDPest was higher in the DCM group compared to
normals, although this difference did not reach statis-
tical signiﬁcance (p ¼ 0:13). The increased end-dias-
tolic pressure is potentially linked to the impaired
motion and lower strains observed in DCM hearts,
with the end-diastolic pressure contributing to the
deterioration of the tissue function and structure due
to growth and remodelling.
Observing the obtained parameter ratios in Fig. 7a,
it is worth noting that c values were signiﬁcantly lower
than 1. This ﬁnding is in agreement with experimental
and modelling studies35 reporting that the myocardial
tissue is stiffer in the ﬁbre direction. Interestingly, c—a
measure of the degree of anisotropy—varied notably
between cases, ranging between 0.09 and 0.65. With no
signiﬁcant difference in c identiﬁed between the vol-
unteer and patient groups, it is possible that the degree
of anisotropy is not markedly affected by the remod-
elling occurring in DCM hearts. However, as c is
dependent on the ﬁbre distribution (Fig. 4), the
observed variation in c could also reﬂect differences in
the ﬁbre architecture amongst cases.
The diﬀerences were more pronounced in the
absolute values of a and af (Fig. 7). Speciﬁcally, both
the isotropic and ﬁbre parameters a and af were dis-
tinctly higher in the DCM group compared to normals
(p ¼ 0:0002 and p ¼ 0:014 respectively). The increase
in the two parameter values indicates increased stiff-
ness in DCM models.
A link between DCM and elevated stiﬀness has been
reported for genetically engineered mice7,27 and
humans5 based on pressure-volume analysis and pa-
tient-speciﬁc modelling.5,27 Increased stiffness appeared
to be related to structural changes such as increase in the
collagen content in the extracellular matrix,6,18 alter-
ations in laminar architecture27 and presence of ﬁbro-
sis,5 which could suggest potential treatment avenues.
Additionally, a larger increase in stiffness was seen to
reﬂect a later stage in the disease progression,5,7 sup-
porting the potential use of stiffness as a clinical index
forDCMassessment. In accordance with these ﬁndings,
our results suggest increased stiffness in DCM hearts
based on more comprehensive data and regional met-
rics. More importantly, the observation of elevated
stiffness was based on a carefully selected model per-
sonalisation process focusing on unique parametrisa-
tion, providing conﬁdence in the parameter estimates
and conclusions.
Study Limitations
It should be noted, that parameter estimates can
only suggest increased stiﬀness within the modelling
framework employed, as model assumptions are likely
to introduce bias into the estimated values. Future
work should therefore be directed towards improving
model accuracy, by addressing remaining model
uncertainties. For instance, as ﬁbre distribution was
seen to signiﬁcantly impact model outcomes, using
in vivo DTMRI data or considering non-symmetric or
nonlinear ﬁbre distributions might prove beneﬁcial for
model ﬁdelity. Additionally, the RV BC could be
augmented to also account for the inﬂuence of the RV
cavity pressure. Due to the absence of invasive RV
cavity pressure or a reliable data-derived estimate, a
simpler epicardial condition was used. Model ﬁdelity
and parameter accuracy could also be enhanced by
allowing for regional variation in parameters and
considering orthotropic material laws. Further
improvement in model accuracy could be achieved by
estimating the reference conﬁguration through an in-
verse approach,13 for which, however, invasive pres-
sure measurements would be necessary. Finally,
important model uncertainties could be clariﬁed over
model validation, which would however require a large
variety of invasive in vivo and ex vivo data.
Additionally, the accuracy of the model-derived
stiﬀness could be aﬀected by data-related factors. As
parameter estimates are linearly dependent on EDPest
(Eq. 8), any error in the pressure estimation would be
directly propagated to the parameter estimates.
Parameter accuracy could thus be improved using
pressure measurements, which are however invasive.
Hence a non-invasive alternative was used that was
veriﬁed over healthy volunteers and DCM patients.26
Furthermore, the resolution and noise in TMRI and
cine MRI images as well as the accuracy of person-
alised segmentations could inﬂuence model outcomes.
Use of more automated segmentation procedures and
uncertainty quantiﬁcation for model geometry will
become increasingly necessary as models move closer
to clinical translation. Additional error could be
incorporated through the motion extraction algorithm
that would propagate on both displacement and vol-
ume data that are key inputs for this work. Although
the processed extracted motion demonstrated low er-
rors against manually tracked landmarks, future work
could be directed towards improving the agreement
between processed data and original images for
example by considering different boundary constraints
over the incorporation of the wall-volume constraint
(Eq. S2). Nevertheless, the obtained parameter esti-
mates with and without the current post-processing
step highlight the same distinction between healthy
volunteers and DCM patients (Figs. 7b, S2).
The presented analysis was focused on diastole,
therefore examining model uncertainties over whole
cycle tests would provide a useful next step. As unique
parametrisation has been established, additional tests
can be performed with increased computational
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eﬃciency using data assimilation techniques. Further-
more, development of more personalised models for
both healthy volunteers and DCM patients would en-
able a more thorough statistical analysis potentially
strengthening our conclusions.
Finally, an interesting future development would be
the use of data-based machine learning algorithms,
which—provided a large enough cohort—could
approximate the physical link between motion and
stiﬀness that is now given by the model. However, such
an endeavour would require a signiﬁcant number of
patients to account for non-trivial variabilities in
structure and function.
CONCLUSIONS
In this work we have collected comprehensive
non-invasive clinical data from a group of healthy
volunteers and DCM patients. Following data pro-
cessing, metrics reported in the clinical literature
were compared between the two groups, demon-
strating signiﬁcant deterioration in function in dis-
eased hearts. Additional insight into cardiac function
in DCM was obtained through patient-speciﬁc
modelling, which enabled comparisons to transition
from image-derived metrics to a model-based tissue
stiﬀness. Acknowledging the need for reliable esti-
mation of model stiﬀness, personalised models were
developed with the objective of achieving suﬃcient
model accuracy and unique parametrisation. Accord-
ingly, key model uncertainties were systematically
examined, elucidating that accounting for the
mechanical inﬂuence of the RV and using a ﬁbre
angle of h ¼ 50 produced consistently lower model
errors and resulted in better identiﬁability charac-
teristics. In fact, the assumed ﬁbre distribution was
shown to signiﬁcantly inﬂuence model outcomes,
highlighting the need for personalised ﬁbre geome-
tries. For all cases, unique parametrisation was
combined with good agreement between model and
data, supporting the adequacy of the employed
model assumptions and the data processing followed.
Passive stiffness was markedly higher in DCM
models, suggesting that future research could be
directed towards understanding its role in the onset
and progression of the disease.
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